Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SymBio On Radar Of VC Firms And Small Biotechs For Tapping Japan's Specialty Market; Signs With Onconova

This article was originally published in PharmAsia News

Executive Summary

TOKYO - SymBio Pharmaceuticals Ltd. is catching the eyes of small biotechs looking for partners in the Japanese market since gaining approval for its first drug last year. Onconova Therapeutics Inc. tied up with SymBio in Japan and South Korea for the first commercial license of its lead compound, the multikinase inhibitor rigosertib

Latest Headlines
See All
UsernamePublicRestriction

Register

SC078564

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel